Cyclopharm Limited announced a private placement of 100,000 common shares at an issue price of AUD 2.18 for the gross proceeds of AUD 218,000 on April 17, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.72 AUD | +0.58% | -4.44% | -10.65% |
Mar. 19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
Mar. 18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.65% | 107M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- Cyclopharm Limited announced that it expects to receive AUD 0.218 million in funding